Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Recordati has completed its acquisition of Orphan Europe, a Paris-based pharmaceuticals group which focuses upon the development of treatments for rare diseases, in a deal valued at E135 million.
Subscribe to our email newsletter
Orphan Europe employs about 120 personnel, and has subsidiaries in nine European countries and in the United Arab Emirates as well as representative offices in seven countries. Recordati’s current and growing coverage of the European pharmaceutical market makes it a partner of choice for new product licenses from companies which do not have European marketing organizations.